Sharekhan

Lasa Supergenerics Ltd

Wed 11/06/2025,16:14:45 NSE: LASA

₹ 13.37 0.16 (1.21%)
BUY NOW Buy Lasa Supergenerics Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Lasa Supergenerics Ltd

Wed 11/06/2025,16:1:0

Lasa Supergenerics Ltd

Wed 11/06/2025,16:14:45 | NSE : LASA

₹ 13.370.16 (1.21%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 13.21

Previous Close

₹ 13.21

Volume

81505

Mkt Cap ( Rs. Cr)

₹66.99

High

₹ 13.74

Low

₹ 12.90

52 Week High

₹ 33.49

52 Week Low

₹ 12.90

Book Value Per Share

₹ 16.71

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Lasa Supergenerics Ltd

Your Vote -

Buy

26.92%

Hold

3.85%

Sell

69.23%

26.92%

26 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

14.07

799

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

799

Option Chain

Analyzes market sentiment, predicts Lasa Supergenerics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Lasa Supergenerics - General Updates

    3 Jun 2025, 4:18PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Related Party Transactions

    28 May 2025, 5:58PM Lasa Supergenerics Limited has informed the Exchange about related Party Transactions

  • Lasa Supergenerics - Outcome of Board Meeting

    28 May 2025, 5:33PM Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

  • Lasa Supergenerics - Integrated Filing- Financial

    28 May 2025, 5:19PM Integrated Filing

  • Lasa Supergenerics - Outcome of Board Meeting

    28 May 2025, 4:16PM Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on May 28, 2025.

  • Lasa Supergenerics - Related Party Transaction For The Quarter And The Year Ended March 31, 2025

    28 May 2025, 5:57PM Related party transaction for the quarter and year ended March 31, 2025

  • Lasa Supergenerics posts Q4 net loss of Rs 14.29 cr

    28 May 2025, 5:23PM The company reported standalone net loss during the quarter stood at Rs 14.29 crore as compared to net loss of Rs 15.30 crore in the previous year qua

  • Lasa Supergenerics - Integrated Filing (Financial)

    28 May 2025, 5:08PM Integrated filing (Financials) for the Quarter and the year ended 31st March, 2025

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting

    28 May 2025, 4:14PM Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Boar

  • Lasa Supergenerics - General Updates

    26 May 2025, 9:49PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    21 May 2025, 6:52PM LASA SUPERGENERICS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer

  • Lasa Supergenerics - Outcome of Board Meeting

    21 May 2025, 6:29PM Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on May 21, 2025.

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting

    21 May 2025, 6:27PM Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, we would like to inform you that the Board of Director in their Meeting held today which was

  • Lasa Supergenerics - Strikes/Lockouts/Disturbances

    19 May 2025, 12:21PM Lasa Supergenerics Limited has informed the Exchange about strikes/lockouts/disturbances

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances

    19 May 2025, 12:07PM Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015, and SEBI Circular No. CI

  • Lasa Supergenerics - Board Meeting Intimation

    16 May 2025, 1:50PM LASA SUPERGENERICS LIMITED has informed the Exchange about Board Meeting to be held on 26-May-2025 to inter-alia consider and approve the Audited Fina

  • Lasa Supergenerics - Board Meeting Intimation for The Quarter And The Year Ended March 31, 2025

    16 May 2025, 1:29PM Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider a

  • Lasa Supergenerics - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    13 May 2025, 6:38PM LASA SUPERGENERICS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer

  • Lasa Supergenerics - Cessation

    13 May 2025, 6:37PM Lasa Supergenerics Limited has informed the Exchange regarding Cessation of Mr Umesh Pawar as Executive Director of the company w.e.f. May 13, 2025.

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Resignation of Director

    13 May 2025, 6:01PM With Reference to the above and in Compliance with Regulation 30 of Listing Regulation, We here by Information you that Mr. Umesh S Pawar (DIN: 105397

  • Lasa Supergenerics - General Updates

    6 May 2025, 4:29PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Press Release

    24 Apr 2025, 5:30PM Lasa Supergenerics Limited has informed the Exchange regarding a press release dated April 24, 2025, titled ""Press Release titled Lasa Supergenerics

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 Apr 2025, 5:26PM Press Release titled \ Lasa Supergenerics Limited Announces the Expansion of Manufacturing Capacity of API Albendazole to meet the growing demand\ iss

  • Lasa Supergenerics - Disclosure under SEBI Takeover Regulations

    19 Apr 2025, 11:11PM Omkar P Herlekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial

  • Lasa Supergenerics has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:20PM As of March 2025, 53.65% is owned by Indian Promoters and 46.35% by Public. <p align=justify> Top Promoter holding highest number of shares of Lasa Su

  • Lasa Supergenerics - General Updates

    18 Apr 2025, 3:58PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Declaration With Respect To Non- Applicabitlity Of Large Entity

    18 Apr 2025, 3:53PM Pursuant to SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26 th November , 2018 for fund raising by issuance of debt securities by large entitie

  • Lasa Supergenerics - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    18 Apr 2025, 3:26PM Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    18 Apr 2025, 3:07PM Please find enclosed herewith certificate under regulation 74 (5)of SEBI (Depositories and Participants) Regulations, 2018 for quarter and the year en

  • Lasa Supergenerics - Trading Window-XBRL

    27 Mar 2025, 2:24PM LASA SUPERGENERICS LIMITED has informed the Exchange about Closure of Trading Window

  • Lasa Supergenerics - Trading Window

    27 Mar 2025, 2:20PM Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation

  • Lasa Supergenerics to start trial runs from Nov 25

    23 Nov 2017 , 12:13PM Lasa Supergenerics announces that it will start its pilot production trial runs at its Unit IV from November 25, 2017
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Lasa Supergenerics Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 96.6762 118.2859 148.6341 158.9171 175.9458
Liabilities 96.6762 118.2859 148.6341 158.9171 175.9458
Equity 50.1012 50.1012 40.6727 40.6727 40.6727
Gross Profit 2.1658 -6.5935 15.6327 47.221 29.948
Net Profit -21.7306 -38.6207 -5.3672 22.7777 3.6284
Cash From Operating Activities 2.1387 -17.3004 10.4898 41.3103 13.6224
NPM(%) -20.82 -29.8 -3.91 11.25 2.16
Revenue 104.335 129.5678 137.1267 202.3795 167.2712
Expenses 102.1692 136.1613 121.494 155.1585 137.3232
ROE(%) -25.95 -46.13 -6.41 27.2 4.33

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
16 Sep 2022 0.25 2.5 0 62.35
15 Sep 2021 0.25 2.5 0 73.6

Peers

Other companies within the same industry or sector that are comparable to Lasa Supergenerics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 822.95 2.22 24.39 119.45 337.37 1.09
Amines and Plasticizers Ltd 251.16 -0.08 33.71 72.85 372.61 0.20
Grauer and Weil (India) Ltd 115.60 0.00 33.31 300.16 346.66 0.43
HP Adhesives Ltd 53.09 1.98 26.68 121.64 99.28 0.00

Company Info

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Read More

Parent Organisation

Lasa Supergenerics Ltd.

Founded

11/11/2016

Managing Director

Dr.Omkar Pravin Herlekar

NSE Symbol

LASABE

FAQ

The current price of Lasa Supergenerics Ltd is ₹ 13.37.

The 52-week high for Lasa Supergenerics Ltd is ₹ 13.74 and the 52-week low is ₹ 12.90.

The market capitalization of Lasa Supergenerics Ltd is currently ₹ 66.99. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Lasa Supergenerics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Lasa Supergenerics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Lasa Supergenerics Ltd shares.

The CEO of Lasa Supergenerics Ltd is Dr.Omkar Pravin Herlekar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT